In this study, paired tumor and normal tissues from a cohort of 313 Chinese breast cancer patients were screened for ATK1, PIK3CA, PTEN and TP53 mutations using microfluidic PCR-based target enrichment and NGS technology. The gene discussed is PIK3CA; the disease is breast cancer.